You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High grade bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Bladder Cancer Trial in Nara, Okayama (FE 999326)

Recruiting
  • Bladder Cancer
  • FE 999326
  • Nara, Japan
  • +1 more
Jan 19, 2023

Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

Recruiting
  • Urinary Bladder Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab

Not yet recruiting
  • High Grade Urothelial Carcinoma
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jan 5, 2023

Non-muscle-invasive Bladder Cancer Trial (STM-416)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Jan 25, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Aug 24, 2022

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

Terminated
  • Advanced Solid Tumor
  • +3 more
  • Darlinghurst, New South Wales, Australia
  • +1 more
Dec 18, 2022

Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • BCG combined with Tislelizumab
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 12, 2022

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Non-muscle Invasive Bladder Cancer Trial in Hanover, Mount Laurel, Rochester (TARA-002)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • Los Angeles, California
  • +11 more
Jan 31, 2023

Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)

Terminated
  • Bladder Cancer
  • Bladder Urothelial Carcinoma
  • re-TURBT
  • 6 weeks BCG instillation
  • Toronto, Ontario, Canada
    University Health Network
Apr 12, 2022

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction Trial in Boston (Samples)

Not yet recruiting
  • Cancer Risk
  • +30 more
  • Samples
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 14, 2022

Bladder Cancer Trial in United States (N-803 and BCG, N-803)

Recruiting
  • Bladder Cancer
  • Anchorage, Alaska
  • +31 more
Oct 26, 2022

Superficial Bladder Cancer Trial in United States (ADSTILADRIN)

Active, not recruiting
Has Results
  • Superficial Bladder Cancer
  • ADSTILADRIN
  • Gilbert, Arizona
  • +33 more
Dec 2, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Genitourinary Cancer
  • +7 more
  • La Jolla, California
  • +5 more
Jul 5, 2022

Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

Recruiting
  • Astrocytoma
  • +22 more
  • Kogarah, New South Wales, Australia
  • +1 more
Apr 18, 2022

Xpert® Bladder Cancer Monitor Test.

Completed
  • Non-Invasive Bladder Urothelial Carcinoma
  • +2 more
  • Xpert® Bladder Cancer Monitor Test
  • Montpellier, Hérault, France
    Clinique Beau Soleil
Feb 8, 2021

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

    Not yet recruiting
    • Non-Muscle- Invasive Bladder Cancer
    • Durvalumab
    • BCG
    • (no location specified)
    Jul 5, 2023

    Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • HER2
    • (no location specified)
    Jul 16, 2023

    High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

    Not yet recruiting
    • High-risk Non-muscle Invasive Bladder Cancer
    • (no location specified)
    Oct 25, 2023